Antibody therapies are rapidly transforming the treatment landscape of non-Hodgkin lymphoma (NHL). Since the development of rituximab as an anti-CD20...

EHA 2021: antibody therapies for NHL

The Video Journal of Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review!  For more news visit www.vjhemonc.com

Medicine

Health & Fitness

The Video Journal of Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com

Share EHA 2021: antibody therapies for NHL

Sign up to save your podcasts

EHA 2021: antibody therapies for NHL

EHA 2021: antibody therapies for NHL

More shows like VJHemOnc Podcast

Hematologic Oncology Update

Mayo Clinic Talks

The Curbsiders Internal Medicine Podcast

Blood Podcast

CCO Oncology Podcast

Blood Cancer Talks

Two Onc Docs

All Things Amyloid

The Hematology Podcast Series!